S&P 500 top movers: Abbott Laboratories (ABT: NYSE) shares jump to record highs above $100
|- S&P 500 extends rally, notches new record high above 3,500.
- Abbott Laboratories (ABT: NYSE) shares soar on White House deal.
- Coty Inc (COTY: NYSE) shares plummet on disappointing earnings figures.
The S&P 500 Index (SPX) opened modestly higher on Thursday but didn't have a difficult time extending its rally to a fresh record high of 3,501. As of writing, the SPX was up 0.5% on the day at 3,496.
S&P 500 top movers
Earlier in the day, White House spokeswoman announced that the Trump administration reached an agreement with Abbott Laboratories (ABT: NYSE) to purchase rapid coronavirus tests. Under the $750 million deal, the administration will acquire 150 million tests, as reported by Reuters.
Boosted by this development, ABT surged to an all-time high of $114 and was last seen gaining 8.6% on the day at $112,03.
On the other hand, Coty Inc (COTY: NYSE) reported that its net revenue declined by 56% to $922.1 million in Q4, which missed analysts' estimate of $1.34 billion by a wide margin. The cosmetic makers' shares were last seen losing 8.9% on a daily basis at $3.5.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.